David Stewart

David Stewart has a strong background in research and development, with experience spanning various roles in different companies. Currently holding the position of Chief Operating Officer at Theradaptive, David oversees regenerative medicine and combination product technology programs. In their previous roles, David managed teams, developed multiplex immunoassay products, designed biomarker immunoassay development processes, and established product transfer systems. David's expertise ranges from laboratory work to leadership and operational responsibilities.